| Name / ID | Type | Disease | RRID | Causal gene(s) | Mutation | Originating lab |
|---|---|---|---|---|---|---|
| AAR-519-001 | Cell Lines | SACS/ARSACS/SPAX6 | — |
SACS | Protein change: p.P2099L (missense homozygous variant) | University of Bordeaux |
| AAR-545-003 | Cell Lines | SACS/ARSACS/SPAX6 | — |
SACS | Protein change: p.V3545Efs*3 (nonsense compound heterozygous variant) | University of Bordeaux |
| AAR-601-003 | Cell Lines | SACS/ARSACS/SPAX6 | — |
SACS | Protein change: p.L143Lfs*10 (nonsense compound heterozygous variant) | University of Bordeaux |
| AFT-068-005 | Cell Lines | SACS/ARSACS/SPAX6 | — |
SACS | Protein change: p.F2056Ffs*21 (nonsense+missense heterozygous variant) | University of Bordeaux |
| alpha-TTP(-/-) mice | Mouse Models | AVED | — |
TTPA | Homozygous Ttpa knock-out mice | Chugai Pharmaceutical Co., Ltd. |
| alpha-TTP(+/-) mice | Mouse Models | AVED | — |
TTPA | Heterozygous Ttpa knock-out mice | Chugai Pharmaceutical Co., Ltd. |
| ANG-120054380-003 | Cell Lines | SACS/ARSACS/SPAX6 | — |
SACS | Protein change: p.C1285Lfs*8 /(nonsense heterozygous variant) | University of Bordeaux |
| Aptx-/- mice | Mouse Models | AOA1 | — |
APTX | Aptx homozygous knockout mice | London Research Institute |
| ARSACS 3 | Cell Lines | SACS/ARSACS/SPAX6 | — |
SACS | p.F2780C & p.S3892* (missense/nonsense mutation) | Queen Mary University of London |
| ARSACS carrier line | Cell Lines | SACS/ARSACS/SPAX6 | — |
SACS | c.5151dupA (p.Ser1718fsX1736) (heterozygous carrier) | UCL Queen Square Institute of Neurology |
| AT-FL-65Q | Mouse Models | DRPLA | RRID: MMRRC_000398-MU |
ATN1 | 65Q | Johns Hopkins University School of Medicine |
| AT-FL-65Q;GFP-LC3 | Mouse Models | DRPLA | — |
ATN1 | 65Q with GFP-LC3 | King's College London |
| At65QmNES mice | Mouse Models | DRPLA | — |
ATN1 | 65Q with alteration of nuclear export signal | Johns Hopkins University School of Medicine |
| At65QmNLS mice | Mouse Models | DRPLA | — |
ATN1 | 65Q with alteration of nuclear localization signal | Johns Hopkins University School of Medicine |
| AtmR35X/+; Aptx-/- mice | Mouse Models | AOA1 | — |
APTX | Aptx homozygous knockout with heterozygous R35X mutation in Atm gene (causing ataxia telangiectasia) mice | Harbor UCLA medical Center |
| AtmR35X/R35X; Aptx-/- mice | Mouse Models | AOA1 | — |
APTX | Aptx homozygous knockout with homozygous R35X mutation in Atm gene (causing ataxia telangiectasia) mice | Harbor UCLA medical Center |
| AtmR35X/R35X; Aptx-/+ mice | Mouse Models | AOA1 | — |
APTX | Aptx heterozygous knockout with homozygous R35X mutation in Atm gene (causing ataxia telangiectasia) mice | Harbor UCLA medical Center |
| Atro-118Q transgenic mice | Mouse Models | DRPLA | — |
ATN1 | 118Q | Morgan-Tan International Center for Life Sciences |
| Ax-1 | Cell Lines | SCA2 | — |
ATXN2 | 23/36 CAG | University of Tübingen |
| Ax-2 | Cell Lines | SCA2 | — |
ATXN2 | 22/42 CAG | University of Tübingen |
| AX-25 | Cell Lines | SCA3 | — |
ATXN3 | 70 CAG | University of Tübingen |
| AX-26 | Cell Lines | SCA3 | — |
ATXN3 | 73 CAG | University of Tübingen |
| AX-27 | Cell Lines | SCA3 | — |
ATXN3 | 76 CAG | University of Tübingen |
| Ax-3 | Cell Lines | SCA2 | — |
ATXN2 | 22/38 CAG | University of Tübingen |
| AX1 | Cell Lines | SCA3 | — |
ATXN3 | 23/70 CAG | University of Tübingen |
| AX2 | Cell Lines | SCA3 | — |
ATXN3 | 26/77 CAG | University of Tübingen |
| AX3 | Cell Lines | SCA3 | — |
ATXN3 | 24/73 CAG | University of Tübingen |
| BOR-090711-003 | Cell Lines | SACS/ARSACS/SPAX6 | — |
SACS | Protein change: p.L1180Lfs*7 (nonsense compound heterozygous variant) | University of Bordeaux |
| C1 (MSA-C) | Cell Lines | MSA/OPCA | — |
? | — | University of Milan |
| C111 | Cell Lines | SCA3 | — |
ATXN3 | 13 CAG | Chinese Academy of Sciences |
| C118 | Cell Lines | SCA3 | — |
ATXN3 | 13 CAG | Chinese Academy of Sciences |
| C2 (MSA-C) | Cell Lines | MSA/OPCA | — |
? | Homozygous COQ2 variant (p.A43G) | University of Milan |
| C206 | Cell Lines | SCA3 | — |
ATXN3 | 13 CAG | Chinese Academy of Sciences |
| C21 | Cell Lines | SCA3 | — |
ATXN3 | 13 CAG | Chinese Academy of Sciences |
| CANVAS 1P | Cell Lines | CANVAS | — |
RFC1 | ~380/1200 AAGGG | Michigan Medicine; pub: University of Michigan |
| CANVAS 1P Isogenic | Cell Lines | CANVAS | — |
RFC1 | Deletion expanded allele; ~0/1200 AAGGG | Michigan Medicine; pub: University of Michigan |
| CANVAS 2C Heterozygous | Cell Lines | CANVAS | — |
RFC1 | ~0/1300 AAGGG | Michigan Medicine; pub: University of Michigan |
| CANVAS 2P | Cell Lines | CANVAS | — |
RFC1 | ~800/1000 AAGGG | Michigan Medicine; pub: University of Michigan |
| CANVAS 3P | Cell Lines | CANVAS | — |
RFC1 | ~800/900 AAGGG | Michigan Medicine; pub: University of Michigan |
| CANVAS 4P | Cell Lines | CANVAS | — |
RFC1 | ~1080/1180 AAGGG | Laboratory of Vikram Khuruna, Harvard Medicine pub: University of Michigan |
| CBIGi001-A-29 | Cell Lines | SCA3 | — |
ATXN3 | ATXN3 KO | Clinical biospecimen Imaging and Genetic Repository (CBIG) |
| CENSOi020-A | Cell Lines | SCA2 | CVCL_WP18 |
ATXN2 | 22/38 CAG | Censo and Axol Bioscience Company (CENSO) |
| CENSOi021-A | Cell Lines | SCA3 | CVCL_WP19 |
ATXN3 | 69/14 CAG | Censo and Axol Bioscience Company (CENSO) |
| CENSOi022-A | Cell Lines | SCA3 | CVCL_WP20 |
ATXN3 | 70/26 CAG | Censo and Axol Bioscience Company (CENSO) |
| CENSOi033-A | Cell Lines | SCA3 | CVCL_WP38 |
ATXN3 | 69/25 CAG | Censo and Axol Bioscience Company (CENSO) |
| CENSOi034-A | Cell Lines | SCA3 | CVCL_WP39 |
ATXN3 | 66/29 CAG | Censo and Axol Bioscience Company (CENSO) |
| CENSOi036-A | Cell Lines | SCA7 | CVCL_WP42 |
ATXN7 | 39/10 CAG | Censo and Axol Bioscience Company (CENSO) |
| CENSOi051-A, B | Cell Lines | SCA2 | CVCL_WP60, CVCL_YC22 |
ATXN2 | 22/36 CAG | Censo and Axol Bioscience Company (CENSO) |
| CENSOi056-A | Cell Lines | SCA6 | CVCL_WP65 |
CACNA1A | 23 CAG | Censo and Axol Bioscience Company (CENSO) |
| CENSOi057-A, B | Cell Lines | SCA2 | CVCL_WP66, CVCL_YC24 |
ATXN2 | 22/39 CAG | Censo and Axol Bioscience Company (CENSO) |
Twenty Twenty-Five
Designed with WordPress